Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc
Cash Interest Paid
Arcturus Therapeutics Holdings Inc
Cash Interest Paid Peer Comparison
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
Cash Interest Paid
$27k
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Interest Paid
$42m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
5%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Arcturus Therapeutics Holdings Inc's Cash Interest Paid?
Cash Interest Paid
27k
USD
Based on the financial report for Mar 31, 2024, Arcturus Therapeutics Holdings Inc's Cash Interest Paid amounts to 27k USD.
What is Arcturus Therapeutics Holdings Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
-69%
Over the last year, the Cash Interest Paid growth was -99%. The average annual Cash Interest Paid growth rates for Arcturus Therapeutics Holdings Inc have been -69% over the past three years .